1. Home
  2. MMYT vs EXAS Comparison

MMYT vs EXAS Comparison

Compare MMYT & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

HOLD

Current Price

$73.51

Market Cap

9.0B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.08

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMYT
EXAS
Founded
2000
1995
Country
India
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
11.0B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
MMYT
EXAS
Price
$73.51
$101.08
Analyst Decision
Strong Buy
Buy
Analyst Count
3
20
Target Price
$120.00
$76.38
AVG Volume (30 Days)
823.9K
10.3M
Earning Date
01-22-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$1,011,011,000.00
$3,082,033,000.00
Revenue This Year
$19.90
$19.40
Revenue Next Year
$19.52
$13.51
P/E Ratio
$107.05
N/A
Revenue Growth
14.55
14.47
52 Week Low
$70.10
$38.81
52 Week High
$123.00
$101.87

Technical Indicators

Market Signals
Indicator
MMYT
EXAS
Relative Strength Index (RSI) 40.45 89.74
Support Level $70.75 $100.98
Resistance Level $75.72 $101.43
Average True Range (ATR) 2.58 2.25
MACD 0.69 0.53
Stochastic Oscillator 43.26 97.74

Price Performance

Historical Comparison
MMYT
EXAS

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: